A top NIH National Institute on Aging priority is to improve understanding of the different factors that contribute to disparities among older adults. Recruiting a diverse range of clinical trial participants — including people of different races, ethnicities, genders, and ages — is crucial to meet this goal. Learn more: go.nia.nih.gov/3Y4GfIT
All comments must conform to NIA's comments policy: go.nia.nih.gov/3VazFjD
#diversity #clinicaltrials #Alzheimers #dementia
- Advancing Diversity in Clinical Trials ( Download)
- The Four Phases of Clinical Trials | Diversity in Clinical Trials | AKF ( Download)
- Why Is Diversity in Clinical Trials Important ( Download)
- Why Diversity Matters in Clinical Trials ( Download)
- The Importance of Diversity Within Clinical Trials ( Download)
- How Can We Advance Diversity and Equity in Clinical Trials | Dr. Barbara Bierer ( Download)
- Diversity in clinical trials ( Download)
- IndyGeneUS AI Increases Diversity in Clinical Trials, Advancing Health Equity in Precision Medicine ( Download)
- Advancing Generic Drug Development: Translating Science to Approval 2024 – Day 2 – Part 2 ( Download)
- The Importance of Diversity in Clinical Trials ( Download)
- Patrick’s Story | Why diversity in clinical trials is important | American Kidney Fund ( Download)
- Why diversity matters in clinical trials ( Download)
- Diversity in Clinical Trials ( Download)
- Advancing Diversity in Clinical Trials ( Download)
- Importance of diversity in clinical trials ( Download)